Marine biotoxins are widespread in the environment and impact on human health via contaminated shellfish, causing diarrhetic, amnesic, paralytic or neurotoxic poisoning. In spite of this methods for determining if poisoning has occurred are limited. We show the development of a simple and sensitive luminescence resonance energy transfer (LRET) -based concept which allows the detection of anti-okadaic acid rabbit polyclonal IgG (mouse monoclonal IgG1) using functionalized lanthanide-based nanoparticles. Upon UV excitation, the functionalized nanoparticles were shown to undergo LRET with fluorophore-labeled anti-okadaic acid antibodies which had been captured and bound by okadaic acid-decorated nanoparticles. The linear dependence of fluorescence emission intensity with antigen-antibody binding events was recorded in the nanomolar to micromolar range, while essentially no LRET signal was detected in the absence of antibody. These results may find applications in new, cheap and robust sensors for detecting not only immune responses to biotoxins but to a wide range of biomolecules based on antigen-antibody recognition systems. Further, as the system is based on solution chemistry it may be sufficiently simple and versatile to be applied at point-of-care.
Introduction
Biosensors, based on the detection of targets using biomolecules, have become commonplace in today's world. Such sensors, employing various physiologically-relevant biomolecules have found widespread use in diverse areas, ranging from pathogen detection to diagnosis and tracking of disease progression in humans. 1 While many biosensors have traditionally focused on the use of antibodies for antigen detection, the detection of antibodies is increasingly recognized as an important aspect of biosensor research. Antibodies may be used as biomarkers for following a range of illnesses including tuberculosis, 2 human papillomavirus, 3 and breast cancer. 4 In addition, various conditions such as inflammatory bowel disease or HIV infection 5 may also be followed based on tracking changes to systemic antibody response to gut microbes when the latter's balance is disrupted as a consequence of the disease. Further, determination of antibody presence and concentration provide valuable information on the efficacy of vaccines in inducing an immune response against specific targets such as, for example, malaria.
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In recent years a range of techniques has been developed for the detection and quantification of antibodies against specific antigens, peptides, proteins and various biomolecules. Primary among these are methods derived from enzyme-linked immunosorbent assay (ELISA) in which a complementary biomolecule to the antibody is immobilized on a substrate and, upon binding of the antibody, may be labeled with a fluorescent dye which is interrogated to determine its concentration and by extension the concentration of antibody present. This method has been applied to the detection of a broad spectrum of antibodies ranging from those against Helicobacter pylori 7 to markers in rheumatoid arthritis, 8, 9 lupus 10 and heparin-induced thrombosis. 11 Other related fluorescent marker approaches include, for example, immunoprecipitation assays and recombinant immunofluorescence assays for detection of antibodies to aquaporin-4 in patients with neuromyelitis optica. 12, 13 Increasingly, these sensing techniques are being developed as antigen-bound micro-arrays in which large numbers of antigens are anchored to a substrate to show good sensitivity and low detection limit due to a high fluorescence signal, or a combination of antigens are bound providing a multiparametric sensor for a range of antibodies. 10, 14 An alternative highly sensitive approach to antibody detection and quantification may potentially be based on exploiting resonance energy transfer, a technique based on the excitedstate non-radiative energy transfer between specific donor-acceptor pairs due to dipole-dipole interactions and spatial proximity, with the sensitivity of the technique down to the single target molecule level already having been shown. 15 In fact, the use of fluorescence resonance energy transfer from functionalized terbium chelates to fluorescent organic dyes based on antibodyantigen binding for the detection of total prostate specific antigen has recently been reported. 16 A different concept based on the forced separation of a donor/acceptor pair upon binding to an anti-HIV-1-p17 antibody leading to FRET quenching hence allowing antibody concentration estimation was also recently reported. 17 Further development of these fluorescence techniques may be achieved through taking advantage of the unique optical properties of nano-sized materials. Application of lanthanidebased nanoparticles as donors in such types of assay (luminescence resonance energy transfer; LRET) may be promising for a number of reasons including large Stokes′ shifts, thus avoiding direct excitation of the acceptor, and reduction of background emission in some applications. 18 Further, they have high quantum yields and very narrow emission bands compared to organic fluorophores, and long-lived excited state lifetimes (~1 ms) enable both facile measurement of donor lifetime changes and elimination of short-lived background auto-fluorescence by signal collection after specific time delays. 19, 20 Indeed, detection of resonance energy transfer at the single lanthanide nanoparticle level has also been reported. 21 
Synthesis of LaF 3 :Ce,Tb nanoparticles
All precursor materials were obtained at the highest possible purity and used as received and a Ti:SA amplifier (Legend), at a laser repetition rate of 100 Hz.
Results and Discussion
The as-prepared dry, powdered nanoparticles gave X-ray diffraction peaks which showed a Emission spectra of the LaNP-OA-antiOA antibody-AF488 complex (λ ex 282 nm) for various concentrations of labeled antibodies. Inset: corresponding I 518 /I 490 intensity ratios at peak maxima for different antibody concentrations A corresponding series of control measurements was made for the complex in which no OA had been conjugated to the LaNPs to determine the role of non-specific binding in the LRET process. In the absence of specific antibody-antigen binding no reduction in 490 nm emission intensity was noted for the LaNPs and no increase in AF488 emission at 518 nm was found, indicating that achieving successful resonance energy transfer in this system is essentially a function of specific molecular recognition between OA and anti-OA antibodies.
Such an absence, or very low-level, of non-specific binding is surprising although may be related to steric reasons as LRET shows extreme sensitivity to distance. This means that a sufficiently close approach by the AF488 acceptor to the donor may be disfavored due to hindrance by the specific, and perhaps non-random, orientation of anti-OA antibody-F ab complex with respect to LaNP as has been noted for other systems. 28 Further confirmation of resonance energy transfer within the system was obtained through photoluminescence lifetime measurements which, using a longer gated delay of 500 µs, avoids interference from direct excitation of the AF488 acceptor. For excitation at 266 nm, data showed a mono-exponential decay more than 13% faster for the LaNP-OA-anti-OA antibody-AF488 complex (1.91 ms) compared to the LaNP only (2.20 ms) indicating increased de-excitation efficiency based on energy transfer to the short fluorescence lifetime acceptor.
While much published work has used, for example, streptavidin/avidin-biotin binding for demonstrating proof of concept in resonance energy transfer systems due to their extremely high mutual affinity, 29, 30 whole serum-derived polyclonal antibodies were interrogated in this work as they may be more relevant in a clinical setting. In addition, functionalizing nanoparticles with other OA-group congeners (which have only minor structural changes from the okadaic acid used here) would still be expected to give a FRET signal as polyclonal antibodies are able to recognize multiple epitopes within a specific toxin group or class giving better cross-reactivity and ultimately more robust binding ability to the biotoxin. Indeed, the relative ease with which resonance energy transfer was detected in our system, particularly due to the acceptor emission band at 518 nm not overlapping with other LaNP donor emission lines and hence avoiding the need for peak deconvolution after data acquisition, demonstrates the potential of the technique to detect an immune system response to marine biotoxins. Further, the relative lack of non-specific 
Conclusions
To our knowledge, this work represents the first use of lanthanide nanoparticle-based luminescence resonance energy transfer to labeled antibodies in order to achieve a robust, simple, sensitive and quantitative 'test tube' method for the detection of antibodies against marine biotoxins. This work represents a step towards the development of an integrated 'mixand-shake' solution-based technique which may be applied at point-of-care and does not need highly trained personnel or expensive specialized laboratory equipment but rather a simple handheld fluorometer. Future work should extend this research to an integrated system in which a LRET signal may be detected, for example, by conformational changes upon antibody-antigen binding which may eliminate the antibody labeling step. We expect our work will stimulate further research in the area of physical chemistry to answer important questions, for example determining antigen orientation with respect to the nanoparticle surface and how this modulates its interaction with antibodies, near-surface steric effects and how it affects antibody-antigen binding, impact of tailoring the length and flexibility of the nanoparticle-antigen linkers etc.
Ultimately, such research is expected to have a strong impact on developing strategies for tailored biosensors which will find use in the priority areas of point-of-care medical diagnostics, consumer health, and food quality and safety monitoring.
